Literature DB >> 33844126

"It's more than Just a Job to Them": A Qualitative Examination of Patient and Provider Perspectives on Medication-Assisted Treatment for Opioid Use Disorder.

Matthew R Filteau1, Frances L Kim2, Brandn Green1.   

Abstract

The expansion of access to medication-assisted treatment by states and the federal government serves as one important tool for tackling the opioid crisis. Achieving this goal requires increasing the number of medical professionals who hold DATA Waiver 2000 waived status, which allows providers to prescribe the medication utilized by treatment programs. Waived providers are scarce throughout rural America, placing a potentially large burden on those who do hold a waiver. This paper uses data gathered through qualitative interviews with healthcare workers and patients at MAT clinics in Montana to understand how the relationship between rural healthcare workers and MAT patients contributes to burnout and potential staff turnover in a rural setting. Patients defined quality care via the patient-staff relationship, including expectations of personal support and viewing staff availability as a requirement for their recovery. Healthcare workers, in contrast, refer to their availability to patients as overwhelming and necessary both during and after business hours. These findings illuminate the need to continue expanding MAT access in rural communities, especially in non-specialty care settings including primary care offices and Federally Qualified Health Centers.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Medication Assisted Treatment; Opioid-use disorder; Patient-centered; Rural

Mesh:

Year:  2021        PMID: 33844126     DOI: 10.1007/s10597-021-00824-7

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  15 in total

1.  Counselor emotional exhaustion and turnover intention in therapeutic communities.

Authors:  Hannah K Knudsen; Lori J Ducharme; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2006-07-13

2.  Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.

Authors:  Christopher M Jones; Elinore F McCance-Katz
Journal:  Addiction       Date:  2018-10-15       Impact factor: 6.526

3.  Counselors' Experiences Treating Methadone-maintained Patients with Chronic Pain: A Needs Assessment Study.

Authors:  Declan T Barry; Matthew J Bernard; Mark Beitel; Brent A Moore; Robert D Kerns; Richard S Schottenfeld
Journal:  J Addict Med       Date:  2008-06       Impact factor: 3.702

4.  Why aren't physicians prescribing more buprenorphine?

Authors:  Andrew S Huhn; Kelly E Dunn
Journal:  J Subst Abuse Treat       Date:  2017-04-12

5.  Leaving buprenorphine treatment: patients' reasons for cessation of care.

Authors:  Jan Gryczynski; Shannon Gwin Mitchell; Jerome H Jaffe; Kevin E O'Grady; Yngvild K Olsen; Robert P Schwartz
Journal:  J Subst Abuse Treat       Date:  2013-10-14

6.  Integrating buprenorphine treatment into office-based practice: a qualitative study.

Authors:  Declan T Barry; Kevin S Irwin; Emlyn S Jones; William C Becker; Jeanette M Tetrault; Lynn E Sullivan; Helena Hansen; Patrick G O'Connor; Richard S Schottenfeld; David A Fiellin
Journal:  J Gen Intern Med       Date:  2008-12-17       Impact factor: 5.128

7.  Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up.

Authors:  D S Metzger; G E Woody; A T McLellan; C P O'Brien; P Druley; H Navaline; D DePhilippis; P Stolley; E Abrutyn
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-09

8.  Time-limited buprenorphine replacement therapy for opioid dependence: 2-year follow-up outcomes in relation to programme completion and current agonist therapy status.

Authors:  Hege Kornør; Helge Waal; Leiv Sandvik
Journal:  Drug Alcohol Rev       Date:  2007-03

9.  Prescribing Practices of Rural Physicians Waivered to Prescribe Buprenorphine.

Authors:  C Holly A Andrilla; Cynthia Coulthard; Davis G Patterson
Journal:  Am J Prev Med       Date:  2018-06       Impact factor: 5.043

10.  Implementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio.

Authors:  Todd Molfenter; Carol Sherbeck; Mark Zehner; Andy Quanbeck; Dennis McCarty; Jee-Seon Kim; Sandy Starr
Journal:  Subst Abuse Treat Prev Policy       Date:  2015-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.